Table 1.
Sample Description
| ADHD | TD | difference | |
|---|---|---|---|
| N | 75 | 29 | - |
| Age in years M (SD) | 9.28 (1.34) | 8.83 (1.23) | p = .106 |
| Female | 29% | 34% | p = .785 |
| Non-White | 39% | 31% | p = .619 |
| Task Accuracy M (SD) | 80% (9%) | 85% (7%) | p = .003 |
| Full-Scale IQ M (SD) | 109 (10) | 118 (11) | p = .001 |
| Average ADHD Symptom Severity M (SD) | 1.42 (0.62) | −0.66 (0.59) | p < .001 |
| Individual P3 Trials M (SD) | 25.72 (3.52) | 27.31 (1.87) | p = .004 |
| Trial-Centered P3 Trials M (SD) | 20.49 (3.21) | 21.66 (2.72) | p = .068 |
Note: ADHD = attention deficit hyperactivity disorder; TD = typically developing. M = mean; SD = standard deviation. Average ADHD symptom severity was calculated as the mean severity of parent ratings of 18 ADHD symptoms on the SWAN, with a range of −3 to 3; higher scores indicate greater ADHD symptom severity. Individual P3 and Trial-Centered P3 Trials = the number of trials included in the individual P3 amplitude or trial-centered P3 variables, respectively. Difference tests were independent samples t-tests for continuous variables (age, accuracy, novel trials, IQ); and chi-square tests for categorical variables (female, non-white). Bolded p values indicate statistically significant group differences at p < .05.